RESUMO
This is a review article aiming to make focus on the changes made in the European Society of Hypertension (ESH)/European Society of Cardiology (ESC) guidelines for the management of arterial hypertension with some criticism for each element discussed in the text. Given that in the real world clinical practice physicians would hardly spend the time needed for studying the 77 pages manuscript of the recently released 2013 ESH/ESC hypertension guidelines, the present review summarizes all the significant updates (along with their clinical implications) compared to the 2007 ESH/ESC hypertension guidelines and the 2009 reappraisal document.
Assuntos
Anti-Hipertensivos/uso terapêutico , Pressão Arterial/efeitos dos fármacos , Hipertensão/diagnóstico , Hipertensão/tratamento farmacológico , Padrões de Prática Médica/normas , Determinação da Pressão Arterial/normas , Humanos , Hipertensão/epidemiologia , Hipertensão/fisiopatologia , Valor Preditivo dos Testes , Medição de Risco , Fatores de Risco , Resultado do TratamentoRESUMO
We describe the case of a patient with ulcerative colitis who suffered a pulmonary embolism that caused shock. Despite the high risk of haemorrhagic complications given the underlying disease, thrombolytic treatment was administered with a good result. Deep vein thrombosis in the lower limbs and pulmonary embolism are the most common thromboembolic phenomena in patients with inflammatory bowel disease. The inflammatory and thrombotic processes are connected, creating a vicious circle. Inflammatory bowel disease predisposes to thromboembolic episodes, while thrombosis, if not the initial cause, is at least implicated in maintaining the inflammatory process in ulcerative colitis and Crohn's disease.
